Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Chronic immune stimulation and subsequent Waldenström macroglobulinemia.

Koshiol J, Gridley G, Engels EA, McMaster ML, Landgren O.

Arch Intern Med. 2008 Sep 22;168(17):1903-9. doi: 10.1001/archinternmed.2008.4.

2.

Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: possible role as initiators of autoimmune hemolytic anemia.

Galletti J, Cañones C, Morande P, Borge M, Oppezzo P, Geffner J, Bezares R, Gamberale R, Giordano M.

J Immunol. 2008 Sep 1;181(5):3674-83.

3.

Is BAFF the murderer in lupus?

Youinou P.

Lupus. 2008 Jul;17(7):613-4. doi: 10.1177/0961203308092164. No abstract available.

PMID:
18625632
4.
5.

Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma.

Mellemkjaer L, Pfeiffer RM, Engels EA, Gridley G, Wheeler W, Hemminki K, Olsen JH, Dreyer L, Linet MS, Goldin LR, Landgren O.

Arthritis Rheum. 2008 Mar;58(3):657-66. doi: 10.1002/art.23267.

6.

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.

Ekström Smedby K, Vajdic CM, Falster M, Engels EA, Martínez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC, Dal Maso L, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W.

Blood. 2008 Apr 15;111(8):4029-38. doi: 10.1182/blood-2007-10-119974. Epub 2008 Feb 8.

7.

Recent advances in the genetics of RA susceptibility.

Bowes J, Barton A.

Rheumatology (Oxford). 2008 Apr;47(4):399-402. doi: 10.1093/rheumatology/ken005. Epub 2008 Feb 7. Review.

PMID:
18263596
8.
9.

A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura.

Mittal S, Blaylock MG, Culligan DJ, Barker RN, Vickers MA.

Haematologica. 2008 Jan;93(1):151-2. doi: 10.3324/haematol.11822.

10.

Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.

Goldin LR, Caporaso NE.

Br J Haematol. 2007 Dec;139(5):774-9. Review.

PMID:
18021091
11.

Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Voulgarelis M, Skopouli FN.

Clin Rev Allergy Immunol. 2007 Jun;32(3):265-74. Review.

PMID:
17992593
12.

Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia.

Landgren O, Gridley G, Check D, Caporaso NE, Morris Brown L.

Br J Haematol. 2007 Dec;139(5):791-8. Epub 2007 Oct 17.

PMID:
17941950
13.

B-cell lymphoproliferation in chronic inflammatory rheumatic diseases.

Hansen A, Lipsky PE, Dörner T.

Nat Clin Pract Rheumatol. 2007 Oct;3(10):561-9. Review.

PMID:
17906611
14.

The use of TNF-alpha blocking agents in rheumatoid arthritis: an update.

Toussirot E, Wendling D.

Expert Opin Pharmacother. 2007 Sep;8(13):2089-107. Review.

PMID:
17714062
15.

Multistep pathogenesis of autoimmune disease.

Goodnow CC.

Cell. 2007 Jul 13;130(1):25-35. Review.

16.

Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.

Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA.

JAMA. 2007 May 9;297(18):2010-7.

PMID:
17488966
17.

The non-Hodgkin lymphomas: a review of the epidemiologic literature.

Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D.

Int J Cancer. 2007;120 Suppl 12:1-39. Review.

18.

Infectious agents as causes of non-Hodgkin lymphoma.

Engels EA.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):401-4. Epub 2007 Mar 2. Review.

19.

Hodgkin's lymphoma in systemic lupus erythematosus.

Bernatsky S, Ramsey-Goldman R, Isenberg D, Rahman A, Dooley MA, Sibley J, Boivin JF, Joseph L, Armitage J, Zoma A, Clarke A.

Rheumatology (Oxford). 2007 May;46(5):830-2. Epub 2007 Jan 25. Review.

PMID:
17255135
20.

Genetic basis of Sjögren's syndrome. How strong is the evidence?

Anaya JM, Delgado-Vega AM, Castiblanco J.

Clin Dev Immunol. 2006 Jun-Dec;13(2-4):209-22. Review.

Supplemental Content

Support Center